Global Epilepsy Drugs Market Size & Outlook, 2023-2030
Global epilepsy drugs market, 2018-2030 (US$M)
Global epilepsy drugs market highlights
- The global epilepsy drugs market generated a revenue of USD 10,872.9 million in 2023 and is expected to reach USD 15,355.9 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5.1% by 2030.
- In terms of segment, first generation anti-epileptics accounted for a revenue of USD 10,872.9 million in 2023.
- First Generation Anti-epileptics is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 10,872.9 million |
| Market revenue in 2030 | USD 15,355.9 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | First generation anti-epileptics |
| Fastest growing segment | First Generation Anti-epileptics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | First Generation Anti-epileptics |
Other key industry trends
- In terms of revenue, the North America accounted for 44.6% of the global epilepsy drugs market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epilepsy Drugs Market Scope
Epilepsy Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global epilepsy drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epilepsy drugs market will help companies and investors design strategic landscapes.
First generation anti-epileptics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global epilepsy drugs market based on first generation anti-epileptics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Epilepsy Drugs Product Outlook (Revenue, USD Million, 2018-2030)
- First Generation Anti-epileptics
- Second Generation Anti-epileptics
- Third Generation Anti-epileptics
Reasons to subscribe to Global epilepsy drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global epilepsy drugs market databook
-
Our clientele includes a mix of epilepsy drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global epilepsy drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global epilepsy drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global epilepsy drugs market size, by regions, 2018-2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
